A study by COHERE in EuroCoord has shown that mortality patterns in treated HIV positive people with a high CD4 count who are not injecting drug users are similar to those in the general population.
Accurate and appropriate statistical analyses of the data collected from participating cohorts and clinics are fundamental to the success of the ongoing research agenda in EuroCoord.
A study by the CASCADE Collaboration in EuroCoord has estimated that there will be a substantial increase in the number of HIV positive people who will require treatment within the first 5 years after becoming infected...
The aims and structure of EuroCoord are outlined in a briefing document which is now available
An MRC-funded study supported by EuroCoord published in the Lancet, has shown that 12% of children with HIV develop triple class virological failure by 5 years after starting antiretroviral therapy (ART), and 20% by 8 years.